March 1, 2017
ASKA Pharmaceutical said on February 28 that it has obtained an exclusive option to license development and commercial rights for US drug maker Pieris Pharmaceuticals’ anemia drug PRS-080 in Japan and certain other Asian markets, excluding China. PRS-080 works by...read more